FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula I, with activity towards chemokine receptor, which can be used for treating immune or viral diseases 
I, where R1 is heteroaryl; R2 is H, heteroaryl, OR9 or SR9; R3 is F, Cl, Br, I, C1-C4 halogenalkyl or heteroaryl; R4 is C1-C6 alkyl; R5 is C1-C6 alkyl; R9 is H, C1-C6 alkyl, alkoxyalkyl or heteroaryl; r is 1 or 2.
EFFECT: obtaining new biologically active compounds.
33 cl, 30 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING DIHYDROINDENAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND USING THEM AS PROTEIN KINASE INHIBITOR | 2009 |
|
RU2528408C2 |
| MODULATORS CCR2 | 2016 |
|
RU2726206C2 |
| SOLUBLE C5aR ANTAGONISTS | 2017 |
|
RU2748260C2 |
| 3-AMINOPYRROLIDINE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | 2003 |
|
RU2355679C2 |
| 2,3-DIHYDRO-1H-INDEN-1-YL-2,7-DIAZASPIRO[3,5]NONANE DERIVATIVES AND USE THEREOF AS GHRELIN RECEPTOR ANTAGONISTS OR INVERSE AGONISTS | 2011 |
|
RU2524341C2 |
| BENZOXAZINYL-AMIDOCYCLOPENTYL-HETEROCYCLIC MODULATORS OF CHEMOKINE RECEPTORS | 2004 |
|
RU2301802C2 |
| BICYCLIC DIHYDROPYRIMIDINECARBOXAMIDE DERIVATIVES AS RHO-KINASE INHIBITORS | 2017 |
|
RU2778478C2 |
| AZASPIROALKANE DERIVATIVES METALLOPROTEASE INHIBITORS | 2004 |
|
RU2379303C2 |
| MODULATORS OF NUCLEAR RECEPTORS | 2016 |
|
RU2715897C2 |
| BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY | 2012 |
|
RU2662827C2 |
